Condition(s) treated: Acne Vulgaris

Intervention: RelayHealth Website & Digital Camera (Device)

Enrollment status: Recruiting

Sponsor: Massachusetts General Hospital

Principal investigator(s) or official(s):
Joseph C. Kvedar, M.D., Principal Investigator, Affiliation: Massachusetts General Hospital

Overall contact:
Hagit Bergman, M.D., Phone: 617-724-3178, Email: HBERGMAN@PARTNERS.ORG

The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online "E-Visit" application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses:

1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.

2. That providers and patients will be satisfied with this model.

3. That mean wait times for new and return visits will be reduced through the "E-Visit" model.

4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.

Official title: The Development and Evaluation of an "E-Visit" Program for the Management of Acne

Study design: Health Services Research, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study

Primary outcome:
Satisfaction survey as each subject completes the study (approximately six months from enrollment)

Peer review of subject images using the Leeds Technique for Acne Grading at the end of active recruitment

Peer review of subject images using forced choice at the end of active recruitment

Peer review of subject images using a four-point scale at the end of active recruitment

Detailed description: Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases.

Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.

Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:

Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.

Group 2- The second group will have four (4) “e-visits” spaced six weeks apart.

At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.

Minimum eligible age: 12 Years. Eligible gender(s): Both.

Criteria:

Inclusion Criteria:

- Age 12 or older

- Diagnosis of mild to severe facial acne

- Access to a digital camera of one mega pixel or above

- Access to an Internet connection and a computer

- Ability to image self

- MA Blue Cross/ Blue Shield Coverage

Exclusion Criteria:

- Non-English speaking individuals

- Patients taking Accutane for their acne

- Neonatal acne

- Impaired Physical ability to image self

- Impaired Cognitive ability

Hagit Bergman, M.D., Phone: 617-724-3178, Email: HBERGMAN@PARTNERS.ORG

MGH Dermatology Associates, Boston, Massachusetts 02114, United States; Recruiting
Patricia M. Sullivan, Phone: 617-726-6922, Email: PSULLIVAN4@PARTNERS.ORG
Joseph C. Kvedar, M.D., Principal Investigator

Brigham and Women's Hospital Department of Dermatology, Boston, Massachusetts 02115, United States; Recruiting
Lisa M. Irwin, Phone: 617-732-4645, Email: LIRWIN@PARTNERS.ORG
Abrar Qureshi, M.D., M.PH., Principal Investigator

Start date: October 2005
End date: December 2007
Last updated: December 29, 2006

Web SmartSkinCare.com